ESSA Pharma Inc. ("ESSA" or the "Company") (TSX-V: EPI) announced today that it has filed with the Food and Drug Administration ("FDA") in the US an Investigation New Drug ("IND") application...

ESSA Pharma Inc. ("ESSA" or the "Company") (TSX-V: EPI) announced today that it has appointed Mr. Franklin Berger to its board of directors. Mr. Berger's appointment as an independent director is...

ESSA Pharma Inc. ("ESSA" or the "Company") (TSX-V: EPI) today reported financial results for the first quarter and three months ended December 31, 2014. Amounts, unless specified otherwise, are...

ESSA Pharma Inc. ("ESSA" or the "Company") (TSX-V: EPI) and Bloom Burton & Co. Ltd. ("Bloom Burton") today announced that they have released from voluntary contractual lock-up (the "Lock-Up")...

ESSA Pharma Inc. ("ESSA" or the "Company") (TSX-V: EPI) announced today that it has submitted to the United States Securities and Exchange Commission ("SEC") a registration statement on Form 20-F...

/NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER U.S. NEWSWIRES/ VANCOUVER, Jan. 27, 2015 /CNW/ - ESSA Pharma Inc. ("ESSA" or the "Company") (TSX-V: EPI) announced today that the Company's...

ESSA Pharma Inc. ("ESSA" or the "Company") filed its financial and operating results today for the fourth quarter and the year ended September 30, 2014. ESSA's highlights for the fiscal year 2014...

/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ VANCOUVER, Jan. 19, 2015 /CNW/ - ESSA Pharma Inc. ("ESSA" or the "Company") announced today that it has...

ESSA Pharma Inc. ("ESSA" or "the Company") today announced that it has received a receipt for a final prospectus that was filed with securities regulators in British Columbia, Alberta and Ontario...

Educating your customers and prospects by sharing expertise and insight is at the heart of content marketing. According to a recent article by Joe Pulizzi, "Lethal Generosity: The Key to Your...